Ma J, Luu B, Ruderman S, Whitney B, Merrill J, Mixson L
AIDS Care. 2023; 36(5):618-630.
PMID: 37419138
PMC: 10771542.
DOI: 10.1080/09540121.2023.2223899.
Brombin C, Bagaglio S, Cugnata F, Castagna A, Uberti-Foppa C, Salpietro S
Sci Rep. 2022; 12(1):18575.
PMID: 36329104
PMC: 9633692.
DOI: 10.1038/s41598-022-23289-4.
Rungnirundorn T, Krusong K, Kalayasiri R, Maes M
World J Biol Psychiatry. 2021; 23(8):613-621.
PMID: 34895035
PMC: 9991870.
DOI: 10.1080/15622975.2021.2016957.
Truong H, Fatch R, Deeks S, Krone M, Martin J, Hunt P
Curr HIV Res. 2021; 19(6):497-503.
PMID: 34176462
PMC: 10659984.
DOI: 10.2174/1570162X19666210625103902.
Castro-Granell V, Garin N, Jaen A, Casado J, Leal L, Cenoz S
AIDS Behav. 2021; 25(12):3883-3897.
PMID: 33932187
PMC: 8602223.
DOI: 10.1007/s10461-021-03271-3.
Comparative impact of methamphetamine and other drug use on viral suppression among sexual minority men on antiretroviral therapy.
Fulcher J, Javanbakht M, Shover C, Ragsdale A, Brookmeyer R, Shoptaw S
Drug Alcohol Depend. 2021; 221:108622.
PMID: 33631545
PMC: 8321435.
DOI: 10.1016/j.drugalcdep.2021.108622.
Substance Use Predicts Sustained Viral Suppression in a Community Cohort of Sexual and Gender Minority Youth Living with HIV.
Hall C, Morgan E, Bundy C, Foran J, Janulis P, Newcomb M
AIDS Behav. 2021; 25(10):3303-3315.
PMID: 33582890
PMC: 8408832.
DOI: 10.1007/s10461-021-03179-y.
Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.
Pocuca N, Young J, MacQueen D, Letendre S, Heaton R, Geyer M
Drug Alcohol Depend. 2020; 215:108245.
PMID: 32871507
PMC: 7811354.
DOI: 10.1016/j.drugalcdep.2020.108245.
Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV.
Pasipanodya E, Kohli M, Fisher C, Moore D, Curtis B
Harm Reduct J. 2020; 17(1):41.
PMID: 32527276
PMC: 7288402.
DOI: 10.1186/s12954-020-00384-1.
Prevalence of Non-medical Amphetamine Use Among Men with Diagnosed HIV Infection Who Have Sex with Men in the United States, 2015-2016.
Maloney K, Beer L, Tie Y, Dasgupta S
AIDS Behav. 2019; 24(6):1865-1875.
PMID: 31834542
PMC: 11299047.
DOI: 10.1007/s10461-019-02761-9.
An initial randomized controlled trial of behavioral activation for treatment of concurrent crystal methamphetamine dependence and sexual risk for HIV acquisition among men who have sex with men.
Mimiaga M, Pantalone D, Biello K, Hughto J, Frank J, OCleirigh C
AIDS Care. 2019; 31(9):1083-1095.
PMID: 30887824
PMC: 6625920.
DOI: 10.1080/09540121.2019.1595518.
Determining the Roles that Club Drugs, Marijuana, and Heavy Drinking Play in PrEP Medication Adherence Among Gay and Bisexual Men: Implications for Treatment and Research.
Grov C, Rendina H, John S, Parsons J
AIDS Behav. 2018; 23(5):1277-1286.
PMID: 30306433
PMC: 6458096.
DOI: 10.1007/s10461-018-2309-9.
Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.
Socias M, Milloy M
Curr Infect Dis Rep. 2018; 20(9):36.
PMID: 30066113
PMC: 6375705.
DOI: 10.1007/s11908-018-0636-7.
Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy.
Jiang W, Luo Z, Martin L, Wan Z, Fu P, Wagner A
Curr HIV Res. 2018; 16(2):143-150.
PMID: 29968539
PMC: 6115301.
DOI: 10.2174/1570162X16666180703151208.
Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial.
Moore D, Pasipanodya E, Umlauf A, Rooney A, Gouaux B, Depp C
Drug Alcohol Depend. 2018; 189:154-160.
PMID: 29958127
PMC: 6324532.
DOI: 10.1016/j.drugalcdep.2018.05.013.
Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.
Kowalczyk W, Moran L, Bertz J, Phillips K, Ghitza U, Vahabzadeh M
Am J Drug Alcohol Abuse. 2018; 44(5):502-511.
PMID: 29634425
PMC: 6146282.
DOI: 10.1080/00952990.2018.1454933.
Testing the Efficacy of Combined Motivational Interviewing and Cognitive Behavioral Skills Training to Reduce Methamphetamine Use and Improve HIV Medication Adherence Among HIV-Positive Gay and Bisexual Men.
Parsons J, John S, Millar B, Starks T
AIDS Behav. 2018; 22(8):2674-2686.
PMID: 29536284
PMC: 6051905.
DOI: 10.1007/s10461-018-2086-5.
Situational HIV stigma and stimulant use: A day-level autoregressive cross-lagged path model among HIV-positive gay and bisexual men.
Rendina H, Millar B, Parsons J
Addict Behav. 2018; 83:109-115.
PMID: 29338889
PMC: 5963983.
DOI: 10.1016/j.addbeh.2018.01.003.
Validation of the HIV Risk Assessment of Sexual Partnerships (H-RASP): Comparison to a 2-Month Prospective Diary Study.
Swann G, Newcomb M, Mustanski B
Arch Sex Behav. 2017; 47(1):121-131.
PMID: 28733826
PMC: 5756508.
DOI: 10.1007/s10508-017-1033-2.
Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.
Starks T, Millar B, Lassiter J, Parsons J
AIDS Patient Care STDS. 2017; 31(2):78-86.
PMID: 28092450
PMC: 5312573.
DOI: 10.1089/apc.2016.0196.